GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of 7 months in and Apotheke is still the thing I get wrong — 51 comments in the full submission. View in context.
1.8k
c/glp1eu·submitted 1 year ago by u/cardio_endpoint_c

7 months in and Apotheke is still the thing I get wrong

Discussionbranch of 5 comments

Posting this because I searched for it and got nothing useful. Setup: 0.5mg, week 12, constipation present but not ruining anything. I changed exactly one variable — reimbursement — and tracked it for 15 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted it.…

Read the full submission and all 51 comments →

This branch

5 comments, started 1 year ago
u/nl_verzekeringMOD90 points·1 year ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/tove_ogunleye69 points·1 year ago

the the Netherlands answer is not the the Netherlands answer

replysharereportpermalink
u/santiago_rasmussen37 points·1 year ago

EMA notices are different from national ones

replysharereportpermalink
u/sten_bhattacharya34 points·1 year ago

Small correction: the trial was 18 weeks, not 15. Does not change your point but people will quote it.

replysharereportpermalink
u/amira_dumitru49 points·1 year ago

EMA and national agency claims need citation

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/glp1eu
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/eu_apotheke_au/nl_verzekeringu/nordic_pricingu/spain_receta
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →